Krystal Biotech financial statements

크리스탈 바이오테크NASDAQ:KRYS · Nasdaq · Healthcare · sector #17
$326.81-2.40%
2026-10-06 close

Krystal Biotech's published financial data is dated 2026-10-04. 2024 revenue was $291M. 2024 operating profit was $66M.

Reported results

Krystal Biotech notifications

Quantus Signal · live data · not investment advice · Privacy Policy